Details for New Drug Application (NDA): 073529
✉ Email this page to a colleague
NDA 073529 describes DOXAPRAM HYDROCHLORIDE, which is a drug marketed by Chartwell Injectable and Watson Labs and is included in two NDAs. Additional details are available on the DOXAPRAM HYDROCHLORIDE profile page.
The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
Summary for 073529
| Tradename: | DOXAPRAM HYDROCHLORIDE |
| Applicant: | Watson Labs |
| Ingredient: | doxapram hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 073529
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
| Approval Date: | Jan 30, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
